loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 205690 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    The University of Texas MD Anderson Cancer Center

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CHOLINE C-11 (1)

    filter

    01 UNIV TX MD ANDERSON (1)

    filter

    01 INJECTABLE;INTRAVENOUS (1)

    filter

    01 4-100mCi/ML (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Choline C-11

      PDF Supplier PDF
      URL Supplier Web Content
      INJECTABLE;INTRAVENOUS
      4-100mCi/ML
      CHOLINE C-11
      USA
      205690
      2015-10-29
      DISCN
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 205690

      Looking for CTD TGA MCC DOSSIER APPLICATION 205690 1

      19

      The University of Texas MD Anderson Cancer Center, based in U.S.A, is a pharmaceutical company.

      One of their notable products is CHOLINE C-11, with a corresponding application number 205690 and regulatory information .

      proudly manufactured in the

      approval since 2015-10-29

      The University of Texas MD Anderson Cancer Center's CHOLINE C-11 INJECTABLE;INTRAVENOUS, medication with 4-100mCi/ML of CHOLINE C-11.

      Post Enquiry
      POST ENQUIRY